Journal Report

Expert Opinion on Biological Therapy

Download PDF
Journal Information
Journal Title
Expert Opinion on Biological Therapy
Publisher
Taylor and Francis Ltd.
ISSN
1471-2598
E-ISSN
1744-7682
Database
SCOPUS
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Three decades of PRPs: keeping the flame alive for blood as a source of repair and regeneration
Eduardo Anitua, Robert E. Marx
2026-11-5 Pages 1-15
DOI: 10.1080/14712598.2026.2757933
An evaluation of marnetegragene autotemcel for the treatment of severe leukocyte adhesion deficiency type I
Jenni Fleischauer, Michael Rothe, Teng Cheong Ha et al.
2026-11-1 Vol. 26 Issue 11 Pages 1197-1207
DOI: 10.1080/14712598.2026.2753949
The double-edged sword: a contemporary perspective on biologics for anti-cytokine syndromes
Valerie Chiang, Marcus P. H. Man, Philip H. Li
2026-10-31
DOI: 10.1080/14712598.2026.2758529
Current and emerging sublingual immunotherapies for dust mite allergy
Wen-Cheng Zhou, Song Li, Lei Cheng
2026-10-23 Vol. 26 Issue 11 Pages 1259-1272
DOI: 10.1080/14712598.2026.2751908
Biologics in alopecia areata: promise, paradox, and the precision medicine frontier
Zijie Tang, Jintong Wu, Chengxin Li et al.
2026-10-23 Vol. 26 Issue 11 Pages 1273-1281
DOI: 10.1080/14712598.2026.2753332
An evaluation of sacituzumab tirumotecan for the treatment of NSCLC
Jingyi Wang, Yu Zhou, Lin Wu
2026-10-21 Vol. 26 Issue 11 Pages 1185-1196
DOI: 10.1080/14712598.2026.2742404
RNA-targeting therapeutics for rare neuromuscular diseases: progress, challenges, and the path toward personalized treatment
Harry Wilton-Clark, Toshifumi Yokota
2026-10-20 Vol. 26 Issue 11 Pages 1175-1178
DOI: 10.1080/14712598.2026.2743265
Emerging therapeutic strategies and clinical trials in severe asthma management: current evidence and future directions
Remo Poto, Rory Chan, Giovanni Paoletti et al.
2026-10-15 Vol. 26 Issue 11 Pages 1239-1257
DOI: 10.1080/14712598.2026.2748260
The cost of delay: foregone public expenditure savings from delayed adalimumab biosimilar listing in Australia’s Pharmaceutical Benefits Scheme
Chin Hang Yiu, Richard O. Day, Jacques Raubenheimer et al.
2026-10-14 Vol. 26 Issue 11 Pages 1299-1306
DOI: 10.1080/14712598.2026.2746447
Changes in the FIB-4 index with IL-23 vs IL-17 inhibitors in psoriasis: a retrospective cohort study
Gozde Ulutaş Demirbas, Abdullah Demirbas, Esin Diremsizoglu
2026-10-13 Vol. 26 Issue 11 Pages 1291-1298
DOI: 10.1080/14712598.2026.2746892
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 6, 2026 15:33